Johan M. Spoor - Nov 25, 2024 Form 4/A - Amendment Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
CEO, Director
Signature
/s/ Johan (Thijs) Spoor by Chris Nenno, as Attorney-in-Fact
Stock symbol
CATX
Transactions as of
Nov 25, 2024
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/4/2024, 05:15 PM
Date Of Original Report
Nov 26, 2024
Previous filing
Jun 24, 2024
Next filing
Dec 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CATX Common Stock 28.3K Nov 25, 2024 Direct F1
holding CATX Common Stock 5.4K Nov 25, 2024 By IRA of Reporting Person
holding CATX Common Stock 12.6K Nov 25, 2024 By IRA of Spouse F2
holding CATX Common Stock 1K Nov 25, 2024 By Child F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Beneficial ownership was reported to be 152,072 and should have been reported as 28,257.
F2 Indirect beneficial ownership was reported to be 66,600 and should have been reported as 12,600.
F3 Indirect beneficial ownership was reported to be 10,000 and should have been reported as 1,000.

Remarks:

This Form 4/A is being filed to correct certain previously reported information regarding the beneficial ownership of the Reporting Person as reflected in the original Form 4 filed on November 26, 2024 (the "Original Form 4"). Certain amounts reported in the Original Form 4 did not reflect the 1-for-10 reverse stock split effected by the Issuer in June 2024; such amounts have been updated accordingly herein.